Kyphoplasty Market Size, Share and Global Trend By Product (Balloon, Cement Mixing, Needle, Others), By Application (Kyphosis, Spinal Fractures, Vertebral Alignment Restoration), By End User (Hospitals, Ambulatory Surgical Centers, Clinics) and Regional Forecast, 2024-2032

The prevalence of back pain, spine fractures, and osteoporosis are increasing at an exponential rate globally. According to the International Osteoporosis Foundation (IOF), it is estimated that globally, osteoporosis causes more than 8.9 million fractures every year and an estimated 200 million women are affected annually by Osteoporosis. There are many interventions to reduce the back pain resulting in spine fractures, but many of them are non-invasive and involve huge cost.

Hence, the shift towards less invasive procedures has been observed as a key trend in the global kyphoplasty market. Kyphoplasty is a type of fluoroscopy-guided minimal invasive surgical technique in which acrylic cement is injected into a damaged vertebral area for stabilizing fractures. Kyphoplasty is performed to eliminate or reduce back pain resulting from any kind of spinal fracture, as well as to restore lost vertebral body and correct alignment of the spine.

The other benefits of Kyphoplasty include improvements in mobility and ability to perform daily life activities. With the use of Kyphoplasty devices, the fracture can be treated even on an outpatient basis within one hour, thus reducing the overall healthcare expenditure.

Growing demand for minimally invasive procedures in orthopedics, improving health reimbursements, and increasing health expenditure are likely to drive the global Kyphoplasty market growth during the forecast period. Additionally, an increase in the number of spine fractures and the growing prevalence of osteoporosis are also expected to fuel the global kyphoplasty market industry growth during the forecast years.

However, the associated risk of cement leakage, which can damage the surrounding nerves and spinal canal is a major factor that can inhibit the global Kyphoplasty market growth during the forecast period.

Key Players Covered

Some of the major companies that are present in the global Kyphoplasty market report include Medtronic, Merit Medical Systems, Stryker, DePuy Synthes (Johnson & Johnson Services Inc.), G21 Srl, Alphatec Spine Inc., Taeyeon Medical Co. Ltd., iMEDICOM, Joline GmbH & Co. KG, RONTIS, and others

SEGMENTATION 

As per the current Kyphoplasty Market trends, balloon segment among product segmentation is anticipated to register the largest share in the global kyphoplasty market during the forecast period as they help in a rapid reduction of cement extravasation during vertebroplasty.

Key Insights

• Overview of Prevalence of Spine Fractures of Key Country/Region


• The Regulatory Scenario of Key Country/Region


• Recent Key Industry Developments – Mergers, Acquisitions, and Partnerships.

Regional Analysis

The global kyphoplasty market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global kyphoplasty market during the forecast period owing to increasing adoption of non-invasive surgical techniques, increasing prevalence of osteoporosis. The additionally strong presence of key players in the region and growing investments in research & development activity likely to propel the growth of Kyphoplasty market. Kyphoplasty market in the Asia Pacific region is expected to expand at a significant rate owing to the rising patient pool and growing healthcare infrastructure. 

Kyphoplasty Industry Developments

• In October 2018, SAFE ORTHOPAEDICS launched Kyphoplasty System: The SteriSpine VA, a cement injection method, performed with a balloon, which allows Safe Orthopaedics to provide a complete emergency fracture treatment.
• In March 2017, Medtronic received FDA approval to use Kyphos(TM) Xpede Bone Cement for fixation of pathological fractures of the sacral vertebral body or ala using sacral vertebroplasty - expanding the product's indications beyond treatment of vertebral fractures due to osteoporosis, cancer or benign lesions.